Provided by Tiger Trade Technology Pte. Ltd.

Adagene

3.29
+0.01500.46%
Volume:132.32K
Turnover:437.65K
Market Cap:220.57M
PE:-8.71
High:3.55
Open:3.53
Low:3.21
Close:3.27
52wk High:4.85
52wk Low:1.30
Shares:67.14M
Float Shares:58.88M
Volume Ratio:1.28
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3773
EPS(LYR):-0.3750
ROE:-28.50%
ROA:-13.95%
PB:2.47
PE(LYR):-8.76

Loading ...

Adagene enters pact with Incyte for combination of muzastotug, INCA33890

TIPRANKS
·
Apr 02

Adagene announces results from the latest data cut of muzastotug study

TIPRANKS
·
Apr 02

Adagene Prices $70 Million ADS Public Offering

MT Newswires Live
·
Apr 02

Adagene Posts Strong Muzastotug Data and Incyte Collaboration in MSS Colorectal Cancer

TIPRANKS
·
Apr 02

Adagene Prices US$70 Million ADS Offering to Bolster Cancer Immunotherapy Pipeline

TIPRANKS
·
Apr 02

Adagene prices follow-on offering at USD 70 million, ADSs at USD 3.75

Reuters
·
Apr 02

Adagene, Incyte partner to test muzastotug combo in MSS colorectal cancer trial

Reuters
·
Apr 02

Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response

GlobeNewswire
·
Apr 02

Adagene Posts 2025 Results as Muzastotug Data, Partnerships Extend Cash Runway to 2028

TIPRANKS
·
Apr 02

Adagene FY Adj. EPS $(0.24) Misses $(0.15) Estimate, Sales $7.671M Beat $1.667M Estimate

Benzinga Earnings
·
Apr 02

Adagene reports FY25 EPS (24c) vs (51c) last year

TIPRANKS
·
Apr 02

Press Release: Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Apr 02

Adagene Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
Mar 20

Adagene Inc. files Form 3 initial beneficial ownership statement for CFO and Director Man Kin Tam

Reuters
·
Mar 18

Adagene Inc. CEO and Director Peter Luo Files Initial Beneficial Ownership Statement

Reuters
·
Mar 18

Adagene Inc. ED of Human Resources Zhou Ling Files Initial Beneficial Ownership Statement

Reuters
·
Mar 18

Adagene Inc. files initial beneficial ownership statement for Chief Manufacturing Officer Zhao Qinghai

Reuters
·
Mar 18

Adagene Inc. Director Do Cuong V Files Initial Beneficial Ownership Statement

Reuters
·
Mar 18

Adagene to present two ADG126 posters at AACR annual meeting

Reuters
·
Mar 18

Adagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA

GlobeNewswire
·
Mar 18